Billy Evans, partner of Theranos founder Elizabeth Holmes, has launched a new startup named Haemanthus focused on 'human health optimization' via blood testing technology. The startup is developing a machine that utilizes lasers to analyze blood, saliva, and urine for the detection of diseases such as cancer and infections. Initially targeting pet health, Haemanthus plans to expand its offerings to human health. With a funding goal of over $50 million, the project raises eyebrows due to its similarities to the failed Theranos venture, leading potential investors to exercise caution.
Billy Evans, partner of Theranos founder Elizabeth Holmes, is launching a startup called Haemanthus, which focuses on blood testing for health optimization.
The startup aims to use lasers for analyzing blood, saliva, and urine, initially targeting pet health before expanding to human diagnostics.
The company's funding goal is over $50 million, echoing the ambitious pitches made by Theranos despite its controversial history.
Investor Jim Breyer expressed concerns, recalling his team's reasons for previously declining investment in Theranos, reinforcing skepticism around Haemanthus.
Collection
[
|
...
]